RMD.AX - ResMed Inc.

ASX - ASX Delayed Price. Currency in AUD
Currency in AUD

Valuation Measures

Market Cap (intraday) 5
33.78B
Enterprise Value 3
34.58B
Trailing P/E
80.21
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
12.51
Price/Book (mrq)
15.79
Enterprise Value/Revenue 3
12.81
Enterprise Value/EBITDA 6
42.10

Trading Information

Stock Price History

Beta (5Y Monthly) 0.42
52-Week Change 341.64%
S&P500 52-Week Change 325.98%
52 Week High 323.36
52 Week Low 312.65
50-Day Moving Average 322.39
200-Day Moving Average 320.39

Share Statistics

Avg Vol (3 month) 3703.75k
Avg Vol (10 day) 3461.88k
Shares Outstanding 51.44B
Float 1.42B
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.23
Forward Annual Dividend Yield 40.98%
Trailing Annual Dividend Rate 31.52
Trailing Annual Dividend Yield 36.57%
5 Year Average Dividend Yield 4N/A
Payout Ratio 413.45%
Dividend Date 3N/A
Ex-Dividend Date 4Nov 06, 2019
Last Split Factor 22:1
Last Split Date 3Aug 12, 2010

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Jun 30, 2019
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 15.52%
Operating Margin (ttm)24.56%

Management Effectiveness

Return on Assets (ttm)11.47%
Return on Equity (ttm)20.86%

Income Statement

Revenue (ttm)2.7B
Revenue Per Share (ttm)1.88
Quarterly Revenue Growth (yoy)15.80%
Gross Profit (ttm)1.54B
EBITDA 821.28M
Net Income Avi to Common (ttm)419M
Diluted EPS (ttm)0.29
Quarterly Earnings Growth (yoy)13.60%

Balance Sheet

Total Cash (mrq)172.15M
Total Cash Per Share (mrq)0.12
Total Debt (mrq)1.31B
Total Debt/Equity (mrq)61.66
Current Ratio (mrq)2.11
Book Value Per Share (mrq)1.47

Cash Flow Statement

Operating Cash Flow (ttm)573.29M
Levered Free Cash Flow (ttm)496.76M